← The frontier
Science & ResearchAug 19, 2026

Intramyocardial injection of allogeneic human induced pluripotent stem cell-derived cardiomyocytes in advanced ischemic heart failure: an early-stage randomized trial.

A treatment for heart failure that could promote myocardial regeneration has long been sought.

A treatment for heart failure that could promote myocardial regeneration has long been sought. Here we conduct the HEAL-CHF trial (n = 20; 18 male and 2 female), in which patients with advanced heart failure with reduced ejection fraction (left ventricular ejection fraction…

The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.